MIRA INFORM REPORT

 

 

Report Date :

7th November 2006

 

IDENTIFICATION DETAILS

 

Name :

MAXHEAL PHARMACEUTICAL NIGERIA LIMITED.

 

 

Registered Office :

18, Oluseun Crescent, Gbagada Phase 1.Lagos

 

 

Country :

Nigeria

 

 

Date of Incorporation :

22nd August, 2002.

 

 

Com. Reg. No.:

459380

 

RATING & COMMENTS

 

MIRA’s Rating :

C

 

RATING

STATUS

PROPOSED CREDIT LINE

<10

C

Absolute credit risk exists. Caution needed to be exercised

Credit not recommended

 

Status :

Undetermined

 

 

Payment Behaviour :

Unknown

 

 

Litigation :

Clear

 

 

 

Name

 

Maxheal Pharmaceutical Nigeria Limited.

 

 

REGISTERED ADDRESS

 

18, Oluseun Crescent, Gbagada Phase 1.Lagos

 

 

Share capital

 

100,000

 

 

Registration Number

 

459380

 

 

Date Registered

 

22nd August, 2002.

 

 

DIRECTORS                   SHARES ALLOTTED

 

MADAM M. SAKHALA                                                               80%

MEHUL SAKHALA                                                                     10%

CHRISTOPHER UKAH                                                               10%

 

 

ADDRESS VISITED         OBSERVATION

 

18 Oluseun Crescent, Gbagada Phase 1, Lagos.              We were at Gbagada phase 1 our investigation revealed that Oluseun crescent does not exist. But our enquiry revealed that the following crescent were at Gbagada Phase 1:

 

 

CONCLUSION AND RECOMMENDATION

 

The above information is from corporate affairs commission. Our investigation revealed that subject is a registered company in Nigeria but it was not a going concern business in Nigeria.

We advised that caution must be taken in dealing with the subject.

 

 

 

RATING EXPLANATIONS

 

 

RATING

STATUS

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average/normal.

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

Credit not recommended

NR

In view of the lack of information, we have no basis upon which to recommend credit dealings

No Rating

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions